Liquidia corporationLQDA.US Overview

US StockHealthcare

(No presentation for LQDA)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

LQDA Overall Performance

LQDA AI Analysis & Strategy

LQDA Recent Performance

-0.14%

Liquidia corporation

0.81%

Avg of Sector

-1.14%

S&P500

LQDA PowerScanner

LQDA Key Information

LQDA Valuation Metrics

LQDA Earnings Table

LQDA Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.